Q32BIO ADX-914-202 This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atopic Dermatitis.
Volunteers needed for up to a 28 week long clinical trial with up to 13 office visits for an investigational product. $100.00 stipend available for each office visit completed.
To Qualify, you must meet the following INCLUSION CRITERIA:
1.) 18+ years of age
2.) Have MODERATE to SEVERE eczema (atopic dermatitis)
3.) Minimum of 10% eczema affected body surface area
To Qualify, you must NOT meet the following EXCLUSION CRITERIA:
1.) Weight over 264 lbs at your 1st office visit.
2.) Unwilling to discontinue current atopic dermatitis treatments
3.) Female who is pregnant or breastfeeding
ClinicalTrials.gov Identifier: NCT 05509023
https://clinicaltrials.gov/ct2/show/NCT05509023?term=q32+bio&draw=2&rank=1
q32 bio logo for ADX-914-202 trial
We love our patients, so feel free to visit during normal business hours.
510 S Cowley Spokane, WA 99202
Mon | 09:00 am – 05:00 pm | |
Tue | 09:00 am – 05:00 pm | |
Wed | 09:00 am – 05:00 pm | |
Thu | 09:00 am – 05:00 pm | |
Fri | 09:00 am – 05:00 pm | |
Sat | Closed | |
Sun | Closed |
Copyright © 2024 Principle Research Solutions,llc - All Rights Reserved.
Your One-Stop Research SOLUTION
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.